HLA-B27 as a predictor of effectiveness of treatment with TNF inhibitors in axial spondyloarthritis: data from the Swiss Clinical Quality Management Registry

OBJECTIVE: To explore the impact of the human leucocyte antigen (HLA)-B27 on the effectiveness of tumor necrosis factor inhibitors (TNFi) in patients with axial spondyloarthritis (axSpA). METHODS: A total of 1109 patients with available HLA-B27 status (831 B27+ patients and 278 B27− patients) fulfil...

Descripción completa

Detalles Bibliográficos
Autores principales: Fröhlich, Fabienne, Micheroli, Raphael, Hebeisen, Monika, Kissling, Seraphina, Bürki, Kristina, Exer, Pascale, Bräm, René, Niedermann, Karin, Möller, Burkhard, Nissen, Michael J., Kyburz, Diego, Andor, Michael, Distler, Oliver, Scherer, Almut, Ciurea, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102047/
https://www.ncbi.nlm.nih.gov/pubmed/36574181
http://dx.doi.org/10.1007/s10067-022-06490-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102047/
https://www.ncbi.nlm.nih.gov/pubmed/36574181
http://dx.doi.org/10.1007/s10067-022-06490-8

Ejemplares similares